Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jamil Alenbawi"'
Autor:
Jamil Alenbawi, Yasser A. Al-Sarraj, Umm-Kulthum I. Umlai, Ayat Kadhi, Nagham N. Hendi, Georges Nemer, Omar M. E. Albagha
Publikováno v:
Human Genomics, Vol 18, Iss 1, Pp 1-12 (2024)
Abstract Sitosterolemia is a rare inherited disorder caused by mutations in the ABCG5/ABCG8 genes. These genes encode proteins involved in the transport of plant sterols. Mutations in these genes lead to decreased excretion of phytosterols, which can
Externí odkaz:
https://doaj.org/article/4b41350d245544dabc97274275caff03
Autor:
Muhammad Atif Waheed, Lolwa Al Mannai, Hanan Khudadad, Jamil Alenbawi, Mariama Aminata Mansaray, Samya Al Abdulla
Publikováno v:
JMIR Formative Research, Vol 8, p e42753 (2024)
BackgroundThe global COVID-19 pandemic caused by SARS-CoV-2 created many unprecedented challenges for health care organizations worldwide, placing a great deal of strain on the health care systems, especially access to health care services. To addres
Externí odkaz:
https://doaj.org/article/6c4aaeca74d447729f9d6ee487c59b27
Autor:
Geethanjali Devadoss Gandhi, Waleed Aamer, Navaneethakrishnan Krishnamoorthy, Najeeb Syed, Elbay Aliyev, Aljazi Al-Maraghi, Muhammad Kohailan, Jamil Alenbawi, Mohammed Elanbari, Qatar Genome Program Research Consortium (QGPRC), Borbala Mifsud, Younes Mokrab, Charbel Abi Khalil, Khalid A. Fakhro
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background The genetic architecture underlying Familial Hypercholesterolemia (FH) in Middle Eastern Arabs is yet to be fully described, and approaches to assess this from population-wide biobanks are important for public health planning and
Externí odkaz:
https://doaj.org/article/1923a649220c42af804d280b274f71d7
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 9, p 877 (2021)
The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals
Externí odkaz:
https://doaj.org/article/4a6651c846ee4118a8b82314ca87a5f0
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 877, p 877 (2021)
Journal of Personalized Medicine, Vol 11, Iss 877, p 877 (2021)
The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals